Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

<p>Abstract</p> <p>Background</p> <p>Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines. Higher levels of FGF23 are associated with increased mortality in hemodialysis-patients an...

Full description

Bibliographic Details
Main Authors: Bleskestad Inger H, Bergrem Harald, Hartmann Anders, Godang Kristin, Gøransson Lasse G
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Nephrology
Subjects:
Active vitamin D
Chronic kidney disease
Fibroblast growth factor 23
FGF23
Phosphate-binder
Parathyroid hormone
PTH
Sevelamer carbonate
Online Access:http://www.biomedcentral.com/1471-2369/13/49

Similar Items

Similar Items